Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Cleveland › NPI 1184933608
Physician

Modi, Yasha

Modi, Yasha was paid $280K by Medicaid between Mar 2018 and Nov 2024, across 12 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 22% of everything it billed.

33Billing provider infoMODI, YASHA
CLEVELAND, OH 44195
33aNPI1184933608assigned 10/01/2010
33bProvider typeOphthalmology Physician
28Total paid$280K
24GClaims9,219
24DCodes billed12
24AFirst – last monthMar 2018 – Nov 2024
Compared with peers

Next to other Ophthalmology Physician providers in Ohio

Rank by total paid#21 of 155
Median peer was paid$10K
This provider vs. median27×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018200$6K
20191,183$25K
20201,573$40K
20211,153$33K
20221,673$60K
20231,747$59K
2024incomplete1,690$56K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
67028 Intravitreal injection of a pharmacologic agent 22% 1,217 1,141 $62K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 19% 1,250 1,221 $54K
92134 19% 3,437 3,290 $53K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 14% 740 715 $40K
J0178 Injection, aflibercept, 1 mg 13% 75 65 $36K
92201 5.8% 1,640 1,620 $16K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.8% 243 236 $8K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 1.4% 116 113 $4K
J9035 Injection, bevacizumab, 10 mg 1.4% 104 96 $4K
92226 <1% 342 296 $2K
92250 <1% 39 38 $766.05
92202 <1% 16 15 $153.90

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.